Litigation
Celgene Corporation v. Sun Pharma Global FZE
settled/consent judgment2:19-cv-10099
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Court
- D.N.J.
- Filed
- 2019-04-16
- Terminated
- 2021-06-22
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Celgene asserted the unlisted Orange Book patents '357, '219, and '598 against Sun Pharma Global FZE. The court denied Sun's motion to dismiss, holding § 271(e)(2) jurisdiction does not require Orange Book listing or Paragraph IV certification. Consent judgment entered 2021-06-22, enjoining Sun until expiration of patents including the '598.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).